JP MORGAN/PUT/INTUITIVE SURGICAL/320/0.01/16.01.26 Share Price

Warrant

DE000JK63XY5

Real-time Bid/Ask 07:52:02 03/07/2024 BST
0.19 EUR / 0.21 EUR +5.26% Intraday chart for JP MORGAN/PUT/INTUITIVE SURGICAL/320/0.01/16.01.26
1 month-20.83%
Date Price Change
03/07/24 0.19 0.00%
02/07/24 0.19 +5.56%
01/07/24 0.18 0.00%
28/06/24 0.18 0.00%
27/06/24 0.18 0.00%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 07:26 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying INTUITIVE SURGICAL, INC.
Issuer J.P. Morgan
WKN JK63XY
ISINDE000JK63XY5
Date issued 03/04/2024
Strike 320 $
Maturity 16/01/2026 (563 Days)
Parity 100 : 1
Emission price 0.24
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.35
Lowest since issue 0.18
Delta-0.15x
Omega 3.045
Premium31.97x
Gearing20.42x
Moneyness 0.7292
Difference Strike -118.8 $
Difference Strike %-37.13%
Spread 0.02
Spread %9.52%
Theoretical value 0.2000
Implied Volatility 40.11 %
Total Loss Probability 70.63 %
Intrinsic value 0.000000
Present value 0.2000
Break even 298.51 €
Theta-0x
Vega0.01x
Rho-0.01x

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
438.8 USD
Average target price
428.1 USD
Spread / Average Target
-2.44%
Consensus